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The necessity of adding the adjective inflammatory to the term erythema in
the above title becomes evident when one stops to think that erythema means
redness; a redness which is characterized by its reversibility and disappearance
under pressure. These characteristics can be due to entirely physiological con-
ditions. For example, the cheeks are normally red and hence erythematous. Some
exposed parts of the body are also more erythematous than certain covered
parts. The shade of the erythema can vary from person to person and in the
same person from one moment to another and from one area to another. On the
other hand, there is no doubt that every inflammatory state leads to an erythema.
Such a vascular-circulatory condition is certainly present in inflammations of
any organ or tissue that contains blood vessels.
In order to define erythema and to ascertain its cause, we have to consider
the following essential points: First of all, we must ask whether the mechanism
by which physiological or pathological (inflammatory) erythema is provoked is
always the same. (Since a differentiation cannot be made from the appearance
of the erythema, one could use simple quantitative criteria which would be of
doubtful validity, or the criteria of persistence, which perhaps would have more
significance.)
Secondly, one must ask whether the cause of erythema or the mechanisms
involved in provoking the vasodilation are the same as those producing the other
parts of the inflammatory process. In this respect, reference is made to sub-
stances involved in inflammation or formed in inflammatory processes. One can
even speak of toxins and of substances derived from agents provoking inflamma-
tion or of substances evidently not responsible for the normal mechanism of
vasodilation. Naturally when one speaks of inflammatory erythema, it is es-
sential to know whether these substances have a direct action or are only capable
of acting through an activation or mediation of the normal mechanisms of
vasodilation. If this were so, it would be a pathological inflammatory expression
with its origin not in a pathological mechanism but in those factors which set
the mechanism into motion.
In the third place, it is extremely important to consider, despite the inherent
difficulties, the significance of the erythematous expression in the inflammatory
process, the phases of its evolution which are well known and which have a
certain local and general significance.
In other words, a certain finalism cannot be overlooked unless one wants to
regard the problem of inflammation as a purely morphological one without
consideration for it as an important functional expression of the inflammatory
reaction.
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First we shall consider the mechanism or mechanisms of vasodilation and
then we shall discuss the distinctive characteristics of the erythematous expres-
sion. These distinctive characteristics are above all the color, the temperature,
and the objective condition of the small blood vessels which are actually re-
sponsible for the visible erythematous manifestation. The color of erythema
can vary from a vivid to a cyanotic red, and the local temperature of the cry-
thematous zone may be raised or decreased in comparison with normal skin. By
definition, inflammatory erythema should be a warm erythema, with a raised
temperature and increased blood flow, and therefore with an increased quantity
of blood per unit time and unit of tissue. Naturally, this does not signify that
there cannot be a cyanotic erythematous expression in an inflammatory process.
In that event it is to be attributed to other elements which are in a certain sense
independent of the inflammatory erythema. If, for example, the blood has a low
oxyhemoglobin content, for either local or general reasons, the region involved
by an inflammatory erythema will have a cyanotic color. However, this is not
of importance in connection with the evaluation of the erythema as an expression
of inflammation. Likewise, an inflammatory erythema can be rapidly superim-
posed on a local cyanosis due to completely independent factors (e.g. diminished
reflux permeability, venous vessel obliteration, arterial spasms, disequilibrium
between tissue oxygen need and blood supply, etc.). In other words, cyanosis is
a condition which can accompany the inflammatory erythema, and its genesis
may be found in varied local and general factors capable of modifying the content
of oxygen in the blood of the zones affected. Inflammatory erythema brings about
an increase in temperature and, therefore, an increase in blood flow and these
are substantially responsible for the erythema itself.
Having given the characteristics of inflammatory erythema already known to
ancient medicine ("rubor et tumor cum calore et dolore"), and having stated
that a cyanotic component is to be considered a superimposed phenomenon or at
least a complication due to particular conditions, we must say something about
vasodilation, the essential element in erythema. It is known that vasodilation is
mediated by acetyicholine via nerve paths which act chiefly upon the arterial
wall. These mechanisms via their effects on the arterioles are mainly responsible
for variations in the peripheral blood flow. Blood flow is also controlled by the
lesser or greater permeability of the capillaries which are independent of the
nerve supply. These small vessels are regulated by the conditions in the tissues
such as C02, pH, T 02, etc. (according to Krogh and others) or H substances of
Lewis and their direct action on the capillary walls. It is not very clear whether
the above substances are the cause or an effect of the inflammatory factor.
Reflex nervous alterations at the arteriolar level are responsible for the reflex
halo which accompanies the inflammatory process. There also exist non-reflex
alterations which are dependent on environmental conditions and specific sub-
stances (eventually H substances) which are present even after the nerve tracts
have been cut.
From the above statements, it is evident that in inflammatory erythema, in
addition to the important reflex mechanism, there exists a direct action which
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cannot be suppressed by interrupting the nerve supply. This action is by no
means an elective mechanism, but a more primitive and in a certain sense a
more essential element. The direct response of the smallest vessels is due to
those stimuli which enable the inflammatory process to act on small vessels,
and, therefore, give it its erythematogenic capacity. Although the series of II
substances has continued to be lengthened (choline, acetyicholine, peptone, P
substance of Gaddum, adenylic acid, leucotaxin of Menkin, etc.) there is no
doubt that they have histamine-like action and that it is histamine and its
quantitative variations which are responsible for the inflammatory process.
There exists an "inflammation-histamine" which requires further study and
which undoubtedly is the essential element in the genesis of inflammatory
erythema. In every erythema there exists an alteration in local and general
histamine content which demonstrates the participation of histamine in the
erythematous response. The pathogenetic problem of inflammatory erythema is
therefore the significance of histamine in the genesis of the erythematous process.
The other point that has to be clarified concerns the stimuli capable of en-
gendering the erythematous response. These stimuli have different latent periods
arid different significance varying from case to case. There are categories of
chemical, physical and other stimuli which are all capable of producing erythem-
atous responses but with varying periods of latency.
The number of stimuli capable of causing an inflammatory erythema is prac-
tically unlimited. If the quantity of such factors is excessive, the process passes
from a simple erythema to a more complex change (e.g. vesicle, granuloma, etc.).
The fundamental question must be studied, however, whether the erythema
vhich is produced is due to several mechanisms or whether the same mechanism
may have different periods of latency.
Erythema is present in every inflammatory process which is more severe than
an erythema (vesicular, infiltrative, granulomatous, etc.) and many authors
have maintained that various characteristics of inflammation are caused by
different specific substances. For example, the existence of specific erythemato-
genie substances has been postulated. Vice versa, there could possibly be just
one erythema-producing agent which might enter into play with only one particu-
lar mechanism whatever the cause of the inflammation. The same problem
exists also regarding the other phases of inflammation, but the discussion here
will be limited to the erythema phase. The only way of analyzing these problems
is the adoption of a technic which is capable of giving rise, in a simple and con-
stant manner, to an inflammatory erythema of measurable intensity and extent.
A series of experiments have been performed by Rabito and Flarer in the
hope of studying these problems. Unfortunately, space does not permit me to
present technical details here. The essential conclusions arrived at with regard
to inflammatory erythema, its mechanisms and its relation to the mode of
action of various stimuli, can be summarized as follows: Every stimulus brought
to bear upon the skin and capable of causing an erythema is a stimulus capable
of causing local damage. Such injury has an effect upon the functioning of single
cellular elements which can be damaged or destroyed.
204 THE JOtRNAL OF INVESTIGATIVE DERMATOLOGY
Each damaging action has its own specific character and different damages
consequently have a different period of latency (latency of damage). Thus the
damage due to certain physical stimuli (hot or cold) has an intensity and extent
in relation to the intensity and duration of application and the period of latency
is short. On the other hand such physical stimuli as roentgen rays, radium or
ultraviolet radiation have an entirely different latency and type of damage.
The same applies for chemical and toxic stimuli. The consequence of the latency
of erythema is above all the latency of damage—a phenomenon which depends
on the character of the stimulus.
It is confusing to consider the latency of erythema the action-time of a stimulus
capable of damage. The erythema is simply a fraction of the total latency. In
other words, the latency of the erythema can be constant beginning at the
moment when the specific mechanisms are set in motion. From this arises the
necessity for ascertaining whether the mechanism of erythema is the same, for
example, in the two great categories of erythema, namely brief and long latency.
The results of numerous experiments performed demonstrate clearly that the
type and, therefore, the pathogenesis of the erythema is the same, whether of
short or long latency. The diverse latencies are essentially latencies of damage
due to the various modes of action of the causal stimuli.
Having clarified this first essential point which considers the pathogenesis of
erythema on a single basis, we must consider whether the mode of action of
histamine is a particular phase of the erythema. There is no doubt that histamine
enters in some manner in the inflammatory erythema reaction and that the
reflex part of the erythema response is tied to histamine, and that it is totally
inhibited by antihistamines. The antihistamines in no case can inhibit completely
the entire erythema. Furthermore, under certain conditions, the antihistamines
increase the action of histamine, especially if more histamine is administered
after antihistamines. These interesting results, even though difficult to interpret,
clearly demonstrate that there is a part of the erythema which is independent of
histamine. Even when histamine is inhibited completely in its known effects by
the antihistamines, there is always a part of the erythema response which per-
sists and which under certain conditions is enhanced by antihistamines.
In order to clarify the function and significance histamine plays in inflam-
matory erythema, Rahito and Flarer performed a series of experiments with the
following results: Every erythema reaction of a certain duration, intensity and
extent is accompanied by the local release of histamine capable of action in a
general sense, lessening the intensity of every erythema which is subsequently
induced in the same skin site. This holds true for both the erythema with a long
or a short latent period. Such an attenuating effect can also be produced by
injecting a corresponding dose of histamine subcutaneously. A similar attenua-
tion occurs also at the site of action of an erythema-producing damage. Local
damage due to a stimulus capable of provoking an erythema response produces,
as an immediate effect, a local release of histamine which has an edema-producing
local and general action. This represents the first true elementary inflammatory
phase and leads to a dilution of the causal stimulus (if it is capable of dilution)
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and of all substances derived from the damage itself. In the case of a threshold
stimulus, the reaction can stop at this phase: no erythema is produced because
the damaging substances have been diluted. (For example, the dilution of an
erythematogenic phenol solution applied locally.) An erythematous phase
follows this initial edematous phase when the dilution is inadequate to obviate
the damaging effects of a persistent stimulus. Histamine continues to be liberated
locally due to the damage. It plays an active role in dilating the small vessels
and at the same time if released in sufficient quantity, has a distant edema-
producing action. This in turn, causes an attenuation of erythematous responses
provoked by other agents at a distance during this period.
In other words, histamine has an attenuating edema-producing action with a
rapid local and distant effect which can be inhibited by antihistamines and
which in a certain way can be considered elementary. Following this, and only
secondarily, there is a dilating effect on the small blood vessels. This is not
inhibited by antihistamines and is antagonistic to the primary edema-producing
effect. Hence, histamine plays two, in a sense, antithetical and competitive roles,
initially and directly edematogenic and subsequently erythematogenic. These
are also antithetically influenced by antihistamines which nullify the first effect,
but not the second (erythema) which can even be increased by antihistamines
under certain conditions.
There are completely different conditions during the histaminic edema of
dilution and the erythematous reaction. This can be shown by various methods,
for example by the diffusion of colored substances introduced locally. In the
quick histaminic dilution phase, a dye will diffuse more rapidly, becoming dis-
persed and diluted while in the erythema phase it disappears more rapidly but
diffuses less, indicating that it is removed by a mechanism other than dilution
as in the first phase. Anyone can see how these two phases of the inflammatory
erythematous response have a great significance, and a different effect with
regard to the stimulus and damage.
The dilutive phase is very clear in its significance and effect, and can be con-
sidered the true and elementary initial phase in the inflammatory process. It is
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capable, therefore, in effect, of annulling the stimulus and of causing the "resti-
tutio ad integrum" \vithout an erythematous response. There are still some
obscure points in the significance and character of the erythematous phase.
The first and elementary phase, which can be called the pre-erythematous or
edematogenic or dilutive phase can be demonstrated by experimental evidence.
Here an invisible stimulus has been rendered manifest (by Rabito and Flarer)
by antihistamines. These, by inhibiting the elementary diluting action, render
visible and erythematous a reaction which with the same stimulus but without
antihistaminics is not visible.
Things are different with reference to the disappearance of an existing ery-
thematous response. When an erythema disappears, one could think that this
could be due to a delayed dilutive phase. Here the initial dilution which impedes
the occurrence of an erythema-producing threshold could be capable later of
diluting the same substances so as to cancel in some way the erythematous
response. This phenomenon is demonstrated in figures 1 and 2.
Experiments on latency, intensity and duration of the erythematous response,
however, show that the disappearance of the erythema is not tied to a dilutive
phase similar to the one that precedes it. The second graph, therefore, is not
valid. These data confirm the marked difference between the initial edematogenic
dilutiv3 and pre-erythematous stage and the conditions of the interstitial fluids
when erythema is present. In the ultimate analysis, the data underline the
different functional state of the capillary wall in the initial edematogenic (his-
taminic) phase and in the true erythematous phase. Even at this point there is a
competitive and reciprocally inhibitory action \vhich has a significance in regard
to the different appearance and evolution of the two phases of the inflammatory
reaction: edematogenic and erythematogenic.
In summary, the experimental analysis of the inflammatory erythematous
response has shown the following facets:
1. Action of a stimulus: damage capacity of the stimulus itself; immediate or
later damage according to its character (short or long damage latency).
2. Damage substances and immediate or late latency are the consequences of
the damage itself; they are accompanied by local release of histamine.
3. Histamine has an elementary, edema-producing, diluting action. This is
capable, if the stimulus and the resultant damage are sub-threshold, of canceling
their effects by preventing a visible erythematous reaction. This phase due to
histamine is the first true part of inflammation and can be completely cancelled
by the antihistamines. If such a dilutive effect is lacking a visible erythema
follows due to the inability of the antihistamines to block the erythema, which
depends only in part on the histamine.
4. Histamine, however, also has an erythematous action because the injection
of histamine in an area of erythema increases its intensity and duration. This
action, however, is not elementary and in order for it to become evident the
state of the capillaries has to be different from that during the edema-producing
phase of histaminic action.
5. In other words, there either exist capillary conditioners which render effec-
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tive the vasodilating action of histamine, or the capillary is attacked by histamine
in its edematogenic capacity and not in its erythematogenic function. (Even in
this case, as shown by many other facts, there results a competitive action
between the edematogenic and erythematogenic action.)
The series of these facts are shown in the accompanying scheme. Therefore, the
elementary damaging action caused by any sufficiently intense stimulus (of any
latency period) is to cause release of certain substances derived from cells. These
are: histamine with edematogenic action on the capillaries, substances which
can be defined generically as those that render the capillary walls sensitive to
the dilating erythematogenic action of histamine, and finally, alterations of the
functional necessities of the damaged tissues. It is evident that every change in
the basic tissue needs, e.g. nutritive needs itself will have a modifying effect on
the intensity and threshold of the erythema, providing that the stimulus remains
constant qualitatively and quantitatively. This comes about, for example, in
hyperoxidation (via oxygen administration), in anoxemia, or if we administer
glucose intravenously, or inject insulin. Under all these conditions, which are
capable of modifying the basic tissue needs, the action of a damage-stimulus,
constant in quality and intensity, modifies the erythematous response in the
direction of an increase.
In final analysis, these results show clearly how the modified needs of the
tissue then are the true determining element of the intensity of the erythematous
response. They also lead us to think that the so-called "capillary conditioners"
whose identity has not been demonstrated as yet, act non-specifically modifying
the tissue needs. It is evident then that the character of the erythematous
response as a part of every inflammatory process is quite different from what it
is generally thought to be. Erythema represents a purely physiological and
unitary mechanism which has a constant latency that has little or no connection
with the so-called latency of the various types of erythema-producing stimuli.
The true pathological significance of erythema resides, therefore, only in its
persistence or absolute insufficiency (demonstrated by its persistence independent
of the damage) or in its absence when modified local needs exist which would
require it. While the consequences of a persistent erythema under the former
conditions are obscure, one knows that its absence under the latter conditions
is a grave sign with regard to local consequences as well as an index of a poor
general reactive state.
One cannot conclude this article without saying something about the signifi-
cance of the erythematous reaction in its general scope, since we have a clear
enough concept of its local significance. We have seen that the presence of an
erythema has as an immediate effect, an edematogenic dilutive action tied to
the local production of histamine and to a local and subsequently general edema-
togenic dilutive effect. These are very important points which may be responsible
for a number of clinical facts which accompany the erythematous manifestations.
Besides this edematogenic dilutive action of histamine, a persistent erythema
(Rabito and Flarer have shown this in experiments ad hoc) has a cortisone-like
effect which evidently has its own capacity of local and general action on a
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completely different plane from those Complex effects which a cortisone action
can exercise.
SUMMARY
Summarizing all that has been said above, in order to establish the significance
of the erythematous phase as one particular part of inflammation, we can say
the following: The erythematous phase cannot be considered the first part of
the inflammatory response since this consists of an edematogenic dilutive action
due to the action of histamine.
The erythematous phase, even though to a large extent dependent on his-
tamine, is based on an essentially physiologic and unitary mechanism evolved
to satisfy the local exigencies of the tissues modified hy the stimulus-cause via
its specific damage.
The erythematogenic conditioners are not specifically this or that substance
which have been identified or described from time to time (the major part of
these are to he considered simply substances of damage or stimulus), but all
those conditions capable of creating modified local tissue needs.
There exists, as shown by many viewpoints, a competitive and in a certain
way antagonistic action between the edematogenic and erythematogenic phase
(revealed clearly by the action of histamine and antihistamines) which seems
to me extremely interesting for the study of the character and significance of
the reactive inflammatory phase in general and for its local and general func-
tional and morphologic consequences.
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